Testing of Integrated Human Papillomavirus mRNA Decreases Colposcopy Referrals: Could a Change in Human Papillomavirus Detection Methodology Lead to More Cost-Effective Patient Care? | Zendy

Jennifer L. Sauter | Zendy; Sharon Mount | Zendy; Timothy L. St. John | Zendy; Christina Wojewoda | Zendy; Ronald J. Bryant | Zendy; Gladwyn Leiman | Zendy

Open Access

Testing of Integrated Human Papillomavirus mRNA Decreases Colposcopy Referrals: Could a Change in Human Papillomavirus Detection Methodology Lead to More Cost-Effective Patient Care?

Author(s) -

Jennifer L. Sauter,

Sharon Mount,

Timothy L. St. John,

Christina Wojewoda,

Ronald J. Bryant,

Gladwyn Leiman

Publication year - 2014

Publication title -

acta cytologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.513

H-Index - 57

eISSN - 1938-2650

pISSN - 0001-5547

DOI - 10.1159/000358246

Subject(s) - colposcopy , ascus (bryozoa) , medicine , human papillomavirus , referral , gynecology , obstetrics , cervical cancer , family medicine , cancer , botany , ascospore , spore , biology

This study investigates potential colposcopy referral rates, as per the latest American Society for Colposcopy and Cervical Pathology recommendations, following the change in high-risk human papillomavirus (HR-HPV) detection methodology from Hybrid Capture 2 (HC2) to APTIMA at our institution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research